InvestorsHub Logo
Followers 126
Posts 7322
Boards Moderated 1
Alias Born 12/03/2017

Re: falon post# 186825

Thursday, 09/21/2023 10:06:19 AM

Thursday, September 21, 2023 10:06:19 AM

Post# of 198625
falon - I agree with what you are and have been saying. However, "pre-results," most bios are priced somewhere in between true value and potential value (post-good-results), whereas ENZC has remained below true value for years now. I'm not saying that we should be trading in dollars right now, but I do believe that at the very least we should be trading at no less than 10% of potential/projected value. Using just Clone 3 projections, we should currently be trading around $0.30. Then if we want to even more ultra-conservative, we could say that we should be trading at the MC of the $450M SAGA deal, which would put us around $0.146 using our newly increased OS. Either way, we have been and are still currently undervalued.

Anyway, my point being that I agree they need to produce results for that serious increase we all want to see, but that doesn't change the fact that we are still severely undervalued as we wait; and I believe 100% wholeheartedly that its intentional.


Nobody is going to make money unless the company produce results.

It don't matter who has how many shares or what class of shares.

Bottom line is will the company do any of the following:

1. License agreements

2. Africa ITV-1 treatment success

3. Samsung Biologics Website: https://samsungbiologics.com/en Partnership

4. Scendea USA, Inc. (www.scendea.com) Partnership

5. IPF Immune(TM) revenue

6. SPAC deal with SAGA closes

7. Abveris, a division of Twist Bioscience Corporation https://www.abveris.com/ Partnership

8. Effectiveness of ITV-1 immunotherapy on Diabetes.

9. Clone 3
10. Development of Feline Leukemia Monoclonal Antibodies

11. Clone 7

12. Production Monoclonal Antibodies against HIV

13. Development Monoclonal Antibodies against the Corona Virus

14. Patents protection

15. AI

16. Advancing multiple therapeutics targeting numerous infectious diseases

Nobody knows what the outcome is going to be at the point and time.

The non-binding agreement was made.

The Business Combination Agreement was executed.

De-Spac process is moving forward to the closing of the project.


Will it be a Halloween Treat, an Early Bird Thanksgiving or a Very Merry Christmas?